University of Florida, FL
University of Minnesota, MN
Lift Biosciences, UK
Advent Bioservices, UK
NurExone Biologic, Israel
HepaTx Corporation, CA
Minaris Advanced Therapies is a
global contract development and manufacturing organization (CDMO) and contract testing provider
focused exclusively on cell and gene therapies. The company is headquartered in Philadelphia, Pennsylvania, and has more than 730,000 square feet of
infrastructure across the United States, Europe, and Asia.
Minaris Advanced Therapies has manufactured and released over 7,500 GMP batches and our global network
supports therapy developers through early-stage development, clinical trials, and commercial
manufacturing. By combining scientific expertise with best-in-class manufacturing and testing
services, the company helps bring safe, effective therapies to patients faster and more efficiently.
We cordially invite you to the Global Cell & Gene Therapy Summit-2025, taking place in Orlando, FL, from July 7–9, 2025. Professionals and researchers are encouraged to participate as speakers’ delegates, sponsors, or exhibitors. This three-day conference aims to bring together a global audience to discuss and exchange ideas on the origins, development, clinical applications, and translational science of cell and gene therapy.
The program features talks, poster presentations, workshops, discussions, and networking events, offering a comprehensive experience designed to engage participants in various interactive formats. Attendees will have the opportunity to learn from experts, showcase their research through posters, gain practical insights in workshops, engage in discussions to share perspectives, and connect with professionals from diverse backgrounds.
By fostering such an environment, the Global Cell & Gene Therapy Summit serves as an excellent platform for researchers, clinicians, industry professionals, and other stakeholders to stay updated on the latest advancements in cell and gene therapy. The event also promotes collaboration and knowledge exchange, crucial for accelerating the translation of scientific discoveries into clinical applications.
Ultimately, this summit plays a pivotal role in bridging the gap between academia and industry by fostering collaboration, promoting innovation, and facilitating the dissemination of knowledge in the field of cell and gene therapy.
Collaboration at the Core
CGT-2025 is dedicated to bridging the gap between academia and industry, facilitating partnerships that accelerate research and development in Cell and Gene Therapy.
Networking Opportunities
Connect with leading researchers, industry experts, and decision-makers to explore collaborations, funding opportunities, and strategic partnerships.
Cutting-edge Research
Gain insights into the latest discoveries and advancements in Cell and Gene Therapy through keynote presentations, panel discussions, and interactive sessions.
Industry Impact
Learn how academic research can translate into practical applications that impact the industry, paving the way for transformative therapies and treatments.
Gene Therapy Net is an information resource for both basic and clinical research in gene therapy. The site serves as a network for exchanging gene therapy information and breaking news. Visitors can stay updated on the latest scientific papers, conference announcements, job opportunities, regulations, and guidelines.
Welcome to All Conference Alert, your ultimate guide to global academic conferences! Stay informed about international events across disciplines such as engineering, healthcare, and business. Subscribe for alerts, explore verified listings, and connect with the global academic community.
For regular updates bookmark Global Cell & Gene Therapy Summit website
